Geri Bardelli

Geri Bardelli has extensive experience in clinical operations, with a focus on leadership roles. Geri is currently serving as the Vice President of Clinical Operations at Fore Biotherapeutics since January 2023. Prior to this, they held the position of Vice President of Clinical Operations at Samus Therapeutics, Inc. from October 2021 to January 2023. Before that, they worked at Ziopharm Oncology as the Vice President of Clinical Operations from November 2018 to September 2021, and as the Senior Director of Clinical Operations from August 2017 to November 2018. Geri also gained experience at BioBlast Pharma as the Senior Director of Clinical Operations from May 2016 to July 2017. Earlier in their career, they held various positions at Alexion Pharmaceuticals, Novartis Vaccines and Diagnostics, ImClone Systems (a subsidiary of Eli Lilly and Company), CombinatoRx Inc., and Averion International. Geri started their career as a Clinical Project Manager at the Harvard Clinical Research Institute in March 2000.

Geri Bardelli has a Bachelor of Science (B.S.) degree in Medical Laboratory Science from the University of New Hampshire which they obtained from 1989 to 1993. Geri also attended Merrimack High School from 1985 to 1989, although it is not specified whether they obtained any degrees or certifications from high school. Geri Bardelli has a Master of Business Administration (MBA) degree in Health/Health Care Administration/Management from Suffolk University, although the specific dates are not provided. Geri also has the certification of MT(ASCP) from the American Society for Clinical Pathology (ASCP), although the year of obtaining the certification is not mentioned.